These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Animal experiments on the safety pharmacology of lofexidine. Graf E, Sieck A, Wenzl H, Winkelmann J. Arzneimittelforschung; 1982; 32(8a):931-40. PubMed ID: 6890367 [Abstract] [Full Text] [Related]
4. Acute, subacute and chronic toxicity/Carcinogenicity of lofexidine. Tsai TH, Beitman RE, Gibson JP, Larson EJ, Friehe H, Fontaine R. Arzneimittelforschung; 1982; 32(8a):955-62. PubMed ID: 6890369 [Abstract] [Full Text] [Related]
5. Teratologic and reproductive studies of lofexidine. Tsai TH, Beitman RE, Gibson JP, Larson EJ. Arzneimittelforschung; 1982; 32(8a):962-6. PubMed ID: 6890370 [Abstract] [Full Text] [Related]
6. Toxicology and Carcinogenesis Studies of Hydrochlorothiazide (CAS No. 58-93-5) in F344/N Rats and B6C3F1 Mice (Feed Studies). National Toxicology Program . Natl Toxicol Program Tech Rep Ser; 1989 Jul; 357():1-194. PubMed ID: 12695784 [Abstract] [Full Text] [Related]
14. NTP Toxicology and Carcinogenesis Studies of Promethazine Hydrochloride (CAS No. 58-33-3) in F344/N Rats and B6C3F1 Mice (Gavage Studies). National Toxicology Program . Natl Toxicol Program Tech Rep Ser; 1993 Dec; 425():1-272. PubMed ID: 12616286 [Abstract] [Full Text] [Related]
15. Lofexidine, a new, antihypertensive imidazoline derivative. Clinical profile of action with single-drug treatment and in combination with hydrochlorothiazide. Aigner A, Schmidt U. Arzneimittelforschung; 1982 Dec; 32(8a):976-83. PubMed ID: 6890373 [No Abstract] [Full Text] [Related]
16. Biotransformation of lofexidine in humans. Midgley I, Fowkes AG, Chasseaud LF, Hawkins DR, Girkin R, Kesselring K. Xenobiotica; 1983 Feb; 13(2):87-95. PubMed ID: 6880242 [Abstract] [Full Text] [Related]